202 related articles for article (PubMed ID: 6291831)
1. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
Lee CL; MacDonald GJ; Walsh WF
Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
[No Abstract] [Full Text] [Related]
2. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
3. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
Escobar E; Ojeda G; Saavedra M; Thumala A
Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
[No Abstract] [Full Text] [Related]
4. [Use of captopril in circulatory failure].
Mareev VIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
[No Abstract] [Full Text] [Related]
5. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
[No Abstract] [Full Text] [Related]
6. [Captopril in the treatment of refractory cardiac insufficiency].
Gorb IuG
Ter Arkh; 1985; 57(12):63-7. PubMed ID: 3911466
[TBL] [Abstract][Full Text] [Related]
7. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
Rahn KH; Stumpe KO
MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
[No Abstract] [Full Text] [Related]
8. [Role of the renin-angiotensin system in the regulation of the vascular resistance of chronic heart failure (author's transl)].
Noda H; Tokuyasu Y; Takahahashi S; Nakao H; Kimata S; Hirosawa K; Sugino N
Kokyu To Junkan; 1981 Sep; 29(9):971-6. PubMed ID: 7034102
[No Abstract] [Full Text] [Related]
9. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
Yui Y; Kawai C
Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
[No Abstract] [Full Text] [Related]
10. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic changes during captopril inhibition of the renin-angiotensin-aldosterone system in patients with circulatory failure following heart valve prosthesis].
Anokhin VN; Vladimirov PV; Marshutin NA; Migalina LA; Zenkov VE
Revmatologiia (Mosk); 1988; (2):43-8. PubMed ID: 3051276
[No Abstract] [Full Text] [Related]
12. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
Packer M
Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
[No Abstract] [Full Text] [Related]
13. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
Walsh WF; Lee CL
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
[No Abstract] [Full Text] [Related]
14. Hormone and haemodynamic effects of angiotensin II infusion during captopril treatment for heart failure.
Chambers S; Nicholls MG; Espiner EA; Ikram H; Livesey JH
Horm Metab Res; 1985 Mar; 17(3):159-62. PubMed ID: 2987094
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
17. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
[TBL] [Abstract][Full Text] [Related]
18. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
[No Abstract] [Full Text] [Related]
19. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
Cody RJ; Laragh JH
Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
[TBL] [Abstract][Full Text] [Related]
20. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
